1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A man working in the stock exchange.
    Blue Chip Shares

    2 highly rated ASX 200 shares to buy immediately

    | James Mickleboro

    Here are two buy-rated ASX 200 shares to snap up today...

    Read more »

    a woman rugged up in a woolen hat and gloves with a thermometer in her mouth props her hand under her chin as she looks dejectedly at the camera,, as though she is miserable from feeling sick.
    Healthcare Shares

    Why this top broker is 'cautious' on the outlook for CSL (ASX:CSL) shares

    | Brooke Cooper

    Here's what this broker expects from the CSL share price.

    Read more »

    A couple hold up two gold shopping bags.
    Broker Notes

    2 ASX shares at a golden buying opportunity right now

    | Tony Yoo

    It's sale time! If you like buying your trousers at a discount, why wouldn't you do the same with stocks?

    Read more »

    A man with a wry smile on his face is shown close up behind ascending piles of coins as he places another coin on top of the tallest stack representing rising dividends
    Share Market News

    These ASX 200 shares can beat inflation: expert

    | Sebastian Bowen

    These shares have been named as potential inflation-beaters...

    Read more »

    three young women smile as they hold up their loaded orn chips as they sit in front of a large bowl of dip.
    Share Market News

    Expert tips 3 leading ASX 200 shares to buy on the dip

    | Bernd Struben

    As prices come under pressure, valuations are beginning to look more appealing.

    Read more »

    ASX shares Business man marking buy on board and underlining it
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers rate these ASX shares as buys...

    Read more »

    ASX shares fund manager Rory Hunter
    Ask a Fund Manager

    2 medical tech ASX shares for turbulent times

    | Tony Yoo

    Ask A Fund Manager: SG Hiscock's Rory Hunter tells why his fund is currently overweight on 2 large-cap health technology…

    Read more »

    A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
    Blue Chip Shares

    2 fantastic ASX 200 shares to buy right now

    | James Mickleboro

    These ASX 200 shares could be in the buy zone now...

    Read more »

    A doctor in a white coat with a stethoscope around his neck stands in the hallway of a hospital deep in concentration over a tablet device in his hands.
    Broker Notes

    Can the CSL (ASX:CSL) share price crack the $300 mark in 2022?

    | James Mickleboro

    Can CSL's shares climb beyond $300?

    Read more »

    half a man's face from the nose up peers over a table with a wide eyed, raised eyebrows curious expression while his hands grip either side of the table.
    Ask a Fund Manager

    Do this now to be filthy rich later: expert

    | Tony Yoo

    Ask A Fund Manager: Forager Funds Management's Gaston Amoros recalls his biggest investment regret.

    Read more »

    A woman shouts through a megaphone.
    Blue Chip Shares

    Analysts name 2 ASX 200 blue chip shares with 30% upside

    | James Mickleboro

    These could be the blue chips to buy this month...

    Read more »

    Health workers shake hands and congratulate each other on good news.
    Broker Notes

    Top broker says latest CSL (ASX:CSL) acquisition will boost more than its bottom line. Here's why

    | James Mickleboro

    CSL's shares could be a buy thanks to the Vifor Pharma acquisition...

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note